Solazyme (SZYM) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Cowen Cuts Price Target on Solazyme (SZYM) Following Earnings Results
July 31, 2015 7:56 AM EDTCowen maintained a Market Perform rating on Solazyme (NASDAQ: SZYM), and cut the price target to $3.25 (from $4.00), following its earnings results. Solazyme reported $11.7mn in revenue for the quarter, missing consensus estimates of and $14.3mn. Adjusted EPS was ($0.40) versus consensus estimate of ($0.37).
Analyst... More
